Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory kawasaki disease

Keiichi Hirono, Yasushi Kemmotsu, Helmut Wittkowski, Dirk Foell, Kazuyoshi Saito, Keijirou Ibuki, Kazuhiro Watanabe, Sayaka Watanabe, Keiichirou Uese, Hirokazu Kanegane, Hideki Origasa, Fukiko Ichida, Johhanes Roth, Toshio Miyawaki, Tsutomu Saji

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory kawasaki disease'. Together they form a unique fingerprint.

Medicine & Life Sciences